Skip to main content
    G

    Guardian Pharmacy Services, Inc. (GRDN)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $42.34
    +2.47 (+6.18%)

    Market Cap: $2.53B

    Last updated: Nov 06, 2026 at 4:24 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    89%(8/9)
    Avg Surprise
    +13.50%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.49
    Range$0.43 - $0.52
    7 analysts
    Revenue Consensus
    $406M
    Range$399M - $411M
    7 analysts
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.49$0.43 - $0.52--7--
    Sep 26
    Reported Nov 5
    		$0.30$0.28$0.26 - $0.30+7.14%Beat7
    4
    0
    30d
    		+20.0%
    Jun 26
    Reported Aug 6
    		$0.24$0.24$0.24 - $0.28+0.00%Beat6
    2
    2
    30d
    		+9.1%
    Mar 26
    Reported May 6
    		$0.29$0.24$0.23 - $0.25+20.83%Beat6
    2
    2
    30d
    		+38.1%
    Dec 25
    Reported Mar 11
    		$0.37$0.27$0.26 - $0.28+38.32%Beat4
    4
    0
    30d
    		+55.4%
    Sep 25
    Reported Nov 10
    		$0.25$0.24$0.23 - $0.25+4.17%Beat4
    0
    1
    30d
    		-10.7%
    Jun 25
    Reported Aug 11
    		$0.22$0.22-+0.00%Beat---10.2%
    Mar 25
    Reported May 12
    		$0.21$0.22$0.21 - $0.23-4.55%Miss3
    No revisions (30d)
    		-
    Dec 24
    Reported Mar 26
    		$0.24$0.22$0.21 - $0.22+8.23%Beat3
    No revisions (30d)
    		-
    Sep 24
    Reported Nov 12
    		$0.28$0.19-+47.37%Beat---
    Jun 24
    Reported Aug 22
    		$0.24$0.00-N/ABeat---

    Key Metrics

    Valuation
    P/E Ratio35.28EV/EBITDA19.82x
    Price/FCF29.38xFCF Yield3.40%
    Profitability
    Profit Margin4.50%Operating Margin3.48%
    ROE30.40%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage163.29x
    Current Ratio1.65xQuick Ratio1.33x
    Trading Statistics
    Beta0.06Avg Volume447.44K
    52-Week High$48.3352-Week Low$26.34

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$40.54
    SMA 20$40.27
    SMA 50$41.40
    SMA 200$38.38
    EMA 10$40.80
    EMA 20$40.69
    EMA 50$40.79
    EMA 200$37.98

    MACD

    Line: 0.00Signal: -0.25Hist: 0.25

    ADX

    ADX: 14.7+DI: 26.4-DI: 18.2

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down68.0
    PSAR$39.45

    Bollinger Bands

    Upper Band$42.15
    Lower Band$38.39
    %B Position933%(Upper)
    Band Width1.05

    RSI (14-Day)

    Neutral
    56.4

    Momentum Oscillators

    Stoch %K59.1
    Stoch %D56.2
    Williams %R-22.9
    ROC (10d)7.3%
    Momentum2.90
    CCI (20d)189.1
    MFI (14d)67.7

    Volatility Measures

    ATR (14d)$1.71(4.0%)
    StdDev (20d)0.94
    Hist Vol48.1%(High)

    Volume Flow

    VWAP$41.98
    OBV6.2M
    AD Line4.1M
    CMF (20d)0.097

    Volume Metrics

    Avg Vol (20d)443.6K
    Vol Ratio2.4x(High)
    VWMA (20d)$40.56

    Pivot Points

    R3$44.86
    R2$43.70
    R1$41.78
    Pivot Point$40.62
    S1$38.70
    S2$37.54
    S3$35.62

    Advanced Oscillators

    TSI-0.23
    Ultimate Osc48.2
    KST-36.49

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$371.07M$351.77M$336.60M$397.62M$377.43M$344.33M$329.31M$338.57M$314.39M$300.04M$275.41M$281.07M
    Cost of Revenue$285.85M$271.72M$260.29M$312.11M$302.71M$276.19M$264.96M$271.46M$253.51M$238.75M$220.31M$226.49M
    Gross Profit$85.22M$80.04M$76.31M$85.50M$74.72M$68.15M$64.35M$67.10M$60.88M$61.29M$55.10M$54.58M
    Operating Expenses$60.16M$59.40M$58.63M$54.74M$58.37M$55.57M$51.34M$50.35M$165.49M$44.28M$47.17M$39.05M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$60.16M$59.40M$58.63M$54.74M$58.37M$55.57M$51.34M$50.35M$165.49M$44.28M$47.17M$12.22M
    Operating Income$25.06M$20.64M$17.68M$30.76M$16.35M$12.58M$13.01M$16.75M$-104,613,000$17.00M$7.93M$15.52M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$177,000$154,000$154,000$163,000$160,000$172,000$170,000$421,000$1.03M$1.07M$765,000$739,000
    Income Before Tax$25.98M$29.79M$18.29M$31.10M$16.63M$12.59M$13.11M$16.22M$-105,641,000$15.85M$7.09M$14.56M
    Income Tax Expense$6.86M$7.67M$4.75M$9.83M$7.04M$3.76M$3.83M$4.38M$176,000$0$0$0
    Net Income$19.12M$22.12M$13.54M$21.27M$9.59M$8.83M$9.27M$11.84M$-105,817,000$15.85M$7.09M$12.02M
    EBITDA$32.09M$35.75M$24.42M$37.00M$22.63M$18.25M$18.54M$21.80M$-99,621,000$21.79M$12.61M$20.01M
    EBIT$26.15M$29.95M$18.45M$31.26M$16.79M$12.76M$13.28M$16.64M$-104,615,000$16.91M$7.86M$15.30M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GRDN

    GRDN Valuation and Fair Value

    P/E
    35.3x
    Forward P/E
    28.6x
    EV/EBITDA
    19.8x
    P/FCF
    29.4x
    P/B
    10.0x
    See GNG's fair value

    GRDN Profitability: Margins, ROIC and FCF

    Gross margin
    22.4%
    Operating margin
    3.5%
    Net margin
    4.5%
    ROE
    30.4%
    FCF margin
    6.3%
    FCF yield
    3.4%

    GRDN Competitors

    CompanyTicker
    Xencor IncXNCR
    HUTCHMED DRCHCM
    Neogen CorporationNEOG
    TransMedics Group IncTMDX
    Maravai Lifesciences Holdings IncMRVI
    Xeris Pharmaceuticals IncXERS
    Warby Parker IncWRBY
    Clover Health Investments CorpCLOV

    Sector: Healthcare

    GRDN Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    6
    Hold
    0
    Sell
    0
    Strong Sell
    0

    GRDN Bull Case vs Bear Case

    Bull case

    • 100.0% of GRDN's analyst ratings are Buy or Strong Buy.

    GRDN Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    9.3%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.49

    GRDN Earnings Date

    GRDN reports Mar 9, 2027. The date is estimated.

    GRDN Earnings Call

    The latest GRDN earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    GRDN ETF Holders

    GNG tracks 8 ETFs that hold GRDN. The largest weights:

    1. First Trust Small Cap Growth AlphaDEX Fund (FYC), 0.49% of the fund
    2. Royce Value Trust Inc (RVT), 0.04% of the fund
    3. Vanguard Health Care Index Fund ETF Shares (VHT), 0.02% of the fund
    4. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.02% of the fund
    5. Vanguard Extended Market Index Fund ETF Shares (VXF), 0.01% of the fund
    Open the ETF Stock Exposure tool for GRDN

    Frequently Asked Questions About GRDN

    When does GRDN report earnings?

    Guardian Pharmacy Services, Inc. (GRDN) is expected to report earnings on Mar 9, 2027.

    Does GRDN pay dividends?

    Guardian Pharmacy Services, Inc. (GRDN) does not currently pay a regular dividend.

    What is GRDN's P/E ratio?

    Guardian Pharmacy Services, Inc. has a price-to-earnings (P/E) ratio of 35.28.

    What is GRDN's market cap?

    Guardian Pharmacy Services, Inc. (GRDN) has a market capitalization of $2.53B with a current stock price of $42.34.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In